Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: Role of ΔFosB

Journal of Neuroscience

Volumn 20, Issue 24, 2000, Pages 8965-8971

  Chen, Jingshan ^a   Zhang, Yajun ^a   Kelz, Max B ^a   Steffen, Cathy ^a   Ang, Eugenius S ^a   Zeng, Ling ^a   Nestler, Eric J ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antidepressant treatments; Cdk5; Electroconvulsive seizures; Gene expression; Hippocampus; Inducible transgenic mice; Transcription factors; FosB

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PROTEIN FOS; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ELECTROCONVULSIVE THERAPY; ENZYME INDUCTION; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HIPPOCAMPUS; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRANSGENIC MOUSE;

EID: 0034671284     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-24-08965.2000     Document Type: Article

References (38)

1. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
2. Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death
3. Abnormal Alzhelmer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5
4. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
5. Smaller hippocampal volume in major depression
6. Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders
7. Chronic Fos-related antigens: Stable variants of deltaFosB induced in brain by chronic treatments
8. Transgenic animals with inducible, targeted gene expression in brain
9. Regulation of ΔFosB and FosB-like proteins by electroconvulsive seizure (ECS) and cocaine treatments
10. Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts
11. A molecular and cellular hypothesis of depression
12. Neural plasticity to stress and antidepressant treatment
13. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex
14. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
15. Stress and hippocampal neurogenesis
16. Neuronal cdc2-like kinase: A cdc2-related protein kinase with predominantly neuronal expression
17. Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures
18. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics
19. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments
20. Neurofilaments in health and disease
21. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine
22. Neuronal Cdc2-like kinases: Neuron-specific forms of Cdk5
23. Cortisol levels during human aging predict hippocampal atrophy and memory deficits
24. Increased neurogenesis in a model of electroconvulsive therapy
25. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity
26. ΔFosB: A molecular mediator of long-term neural and behavioral plasticity
27. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
28. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
29. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation
30. Molecular cloning and chromosomal mapping of the mouse gene encoding cyclin-dependent kinase 5 regulatory subunit p35
31. Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth
32. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
33. Glucocorticoids and atrophy of the human hippocampus
34. Hippocampal atrophy in recurrent major depression
35. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus
36. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures
37. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins
38. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system